Nothing Special   »   [go: up one dir, main page]

Vallet et al., 2001 - Google Patents

Endothelial cell dysfunction and coagulation

Vallet et al., 2001

Document ID
3366437211630729206
Author
Vallet B
Wiel E
Publication year
Publication venue
Critical care medicine

External Links

Snippet

Objectives a) To review endothelial properties and to establish how these unperturbed properties contribute to the maintenance of endothelium anticoagulant activity; b) to better understand the relative contributions of endothelial cells and monocytes in sepsis-induced …
Continue reading at journals.lww.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Vallet et al. Endothelial cell dysfunction and coagulation
Hack et al. The endothelium in sepsis: source of and a target for inflammation
Esmon Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation
Joyce et al. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-κB
Levi et al. Endothelium: interface between coagulation and inflammation
Tsujimoto et al. Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis
Nagato et al. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia
Roemisch et al. Antithrombin: a new look at the actions of a serine protease inhibitor
Shito et al. INTERLEUKIN 1 RECEPTOR BLOCKADE REDUCES TUMOR NECROSIS FACTOR PRODUCTION, TISSUE INJURY, AND MORTALITY AFTER HEPATIC ISCHEMIA-REPERFUSION IN THE RAT1
Simpson et al. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion
Maniatis et al. The endothelium in acute lung injury/acute respiratory distress syndrome
Frenette Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion
Lundberg et al. Quantitative measurement of P-and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury
Kyriakides et al. Neutrophil mediated remote organ injury after lower torso ischemia and reperfusion is selectin and complement dependent
Wiedermann et al. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis
Dhainaut et al. Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis
Barrett New ways of thinking about (and teaching about) intestinal epithelial function
Pu et al. Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock
Russell Vasopressin in vasodilatory and septic shock
Uchida et al. The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury
Angele et al. L-arginine: a unique amino acid for restoring the depressed macrophage functions after trauma-hemorrhage
Hashikura et al. LONG-TERM RESULTS OF LIVING-RELATED DONOR LIVER GRAFT TRANSPLANTATION: A SINGLE-CENTER ANALYSIS OF 110 TRANSPLANTS1
Matsuyama et al. Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury
De Campo et al. Stimulation of protease‐activated receptor‐2 inhibits airway eosinophilia, hyperresponsiveness and bronchoconstriction in a murine model of allergic inflammation
Powell et al. Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis